Cargando…
Mechanism of action of hepatitis B virus S antigen transport-inhibiting oligonucleotide polymer, STOPS, molecules
A functional cure of chronic hepatitis B requires eliminating the hepatitis B virus (HBV)-encoded surface antigen (HBsAg), which can suppress immune responses. STOPS are phosphorothioated single-stranded oligonucleotides containing novel chemistries that significantly reduce HBsAgs produced by HBV-i...
Autores principales: | Kao, C. Cheng, Nie, Yuchun, Ren, Suping, De Costa, N. Tilani T.S., Pandey, Rajendra K., Hong, Jin, Smith, David B., Symons, Julian A., Beigelman, Leonid, Blatt, Lawrence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717253/ https://www.ncbi.nlm.nih.gov/pubmed/35024245 http://dx.doi.org/10.1016/j.omtn.2021.12.013 |
Ejemplares similares
-
Targeting TLR9 agonists to secondary lymphoid organs induces potent immune responses against HBV infection
por: Ushach, Irina, et al.
Publicado: (2022) -
Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry
por: Gurard-Levin, Zachary A., et al.
Publicado: (2020) -
Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models
por: Jekle, Andreas, et al.
Publicado: (2023) -
Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus
por: Deval, Jerome, et al.
Publicado: (2014) -
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development
por: Liu, Cheng, et al.
Publicado: (2021)